Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership263,375 shares
Latest Disclosed Value $ 87,142,886
Citigroup Inc ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 263,375 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $75,246,238 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 172,562 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 52.63% during the quarter. The current value of the position is $66,317,825 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 6,000 of underlying shares valued at $1,985,220 USD and put options representing 12,000 of underlying shares valued at $3,970,440 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 263,375 90,813 52.63 87,143 26.99 0.0187
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 172,562 111,696 183.51 68,619 147.24 0.0303
2025-11-10 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 60,866 -187,372 -75.48 27,755 -65.71 0.0124
2025-08-11 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 248,238 53,504 27.48 80,948 53.94 0.0398
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 194,734 107,837 124.10 52,582 157.16 0.0269
2025-02-12 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 86,897 12,626 17.00 20,448 0.10 0.0121
2024-11-12 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 74,271 -327,389 -81.51 20,427 -79.07 0.0118
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 401,660 250,970 166.55 97,603 333.41 0.0625
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 150,690 77,889 106.99 22,521 61.62 0.0148
2024-02-09 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 72,801 -6,698 -8.43 13,935 -1.03 0.0098
2023-12-06 2023-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 79,499 18,295 29.89 14,079 21.11 0.0105
2023-11-09 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 79,499 18,295 14,079 0.0105
2023-08-10 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 61,204 -17,657 -22.39 11,625 -26.41 0.0076
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 78,861 -117,400 -59.82 15,797 -66.13 0.0111
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 196,261 12,231 6.65 46,641 26.62 0.0371
2022-11-10 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 184,030 44,038 31.46 36,835 80.40 0.0264
2022-08-10 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 139,992 82,983 145.56 20,418 119.34 0.0152
2022-05-12 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 57,009 -12,301 -17.75 9,309 -20.80 0.0057
2022-02-10 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 69,310 -1,682 -2.37 11,754 -12.31 0.0063
2021-11-10 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 70,992 -12,160 -14.62 13,404 -4.91 0.0079
2021-08-10 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 83,152 -2,325 -2.72 14,096 16.80 0.0085
2021-05-13 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 85,477 19,962 30.47 12,068 41.73 0.0078
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 65,515 -37,072 -36.14 8,515 -43.00 0.0050
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 102,587 48,994 91.42 14,938 88.18 0.0097
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 53,593 13,395 33.32 7,938 81.48 0.0062
2020-05-12 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 40,198 -16,710 -29.36 4,374 -33.27 0.0040
2020-02-12 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 56,908 -43,894 -43.54 6,555 -19.13 0.0047
2019-11-08 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 100,802 70,078 228.09 8,106 263.50 0.0064
2019-08-12 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 30,724 18,978 161.57 2,230 103.10 0.0018
2019-05-13 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,746 -67,301 -85.14 1,098 -80.95 0.0011
2019-02-12 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 79,047 28,913 57.67 5,764 31.36 0.0058
2018-11-13 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 50,134 11,947 31.29 4,388 16.70 0.0039
2018-08-10 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 38,187 -15,409 -28.75 3,760 -41.09 0.0035
2018-05-11 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 53,596 -31,500 -37.02 6,383 -40.96 0.0053
2018-02-12 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 85,096 52,519 161.21 10,811 182.49 0.0087
2017-11-13 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 32,577 -17,156 -34.50 3,827 -3.53 0.0031
2017-08-11 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 49,733 5,214 11.71 3,967 73.84 0.0036
2017-05-12 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 44,519 -86,520 -66.03 2,282 -53.49 0.0020
2017-02-10 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 131,039 36,612 38.77 4,906 -23.36 0.0044
2016-11-10 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 94,427 13,551 16.76 6,401 42.62 0.0060
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 80,876 6,647 8.95 4,488 -3.67 0.0046
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 74,229 3,794 5.39 4,659 -29.73 0.0052
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 70,435 -24,842 -26.07 6,630 -13.41 0.0066
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 95,277 12,769 15.48 7,657 -22.58 0.0072
2015-08-13 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 82,508 3,756 4.77 9,890 20.27 0.0088
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 78,752 47,827 154.65 8,223 174.10 0.0079
2015-02-17 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 30,925 -54,686 -63.88 3,000 -55.13 0.0027
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 85,611 70,281 458.45 6,686 590.70 0.0058
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,330 -5,573 -26.66 968 -31.00 0.0009
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 20,903 -4,625 -18.12 1,403 -14.56 0.0014
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 25,528 5,841 29.67 1,642 30.32 0.0015
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 19,687 10,009 103.42 1,260 320.00 0.0012
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,678 9,678 300 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 6,000 -75.00 1,985 -79.20 n/a n/a n/a
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 24,000 0.00 9,544 -12.80 n/a n/a n/a
2025-11-10 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 24,000 10,944 n/a n/a n/a
2025-08-11 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 50,000 66.67 13,501 91.26 n/a n/a n/a
2025-02-12 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 30,000 -1.96 7,059 -16.11 n/a n/a n/a
2024-11-12 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 30,600 170.80 8,416 206.56 n/a n/a n/a
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 11,300 -79.82 2,746 -67.20 n/a n/a n/a
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 56,000 124.00 8,369 74.90 n/a n/a n/a
2024-02-09 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 25,000 25.63 4,785 35.78 n/a n/a n/a
2023-12-06 2023-09-30 13F/A ALNYLAM PHARMACEUTICALS COM Call 19,900 3,524 n/a n/a n/a
2023-11-09 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 19,900 3,524 n/a n/a n/a
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 52,000 49.43 12,358 77.39 n/a n/a n/a
2022-11-10 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 34,800 6,966 n/a n/a n/a
2022-08-10 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 18,400 3,005 n/a n/a n/a
2021-05-13 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 16,800 -14.29 2,183 -23.51 n/a n/a n/a
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 19,600 3.16 2,854 1.42 n/a n/a n/a
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 19,000 -6.86 2,814 26.70 n/a n/a n/a
2020-05-12 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,400 13.33 2,221 7.14 n/a n/a n/a
2020-02-12 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 18,000 111.76 2,073 203.07 n/a n/a n/a
2019-11-08 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 8,500 23.19 684 36.53 n/a n/a n/a
2019-08-12 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 6,900 -50.36 501 -61.43 n/a n/a n/a
2019-05-13 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 13,900 -61.28 1,299 -50.36 n/a n/a n/a
2019-02-12 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 35,900 -40.56 2,617 -50.49 n/a n/a n/a
2018-11-13 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 60,400 88.75 5,286 67.70 n/a n/a n/a
2018-08-10 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 32,000 37.93 3,152 14.08 n/a n/a n/a
2018-05-11 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 23,200 -63.81 2,763 -66.07 n/a n/a n/a
2018-02-12 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 64,100 -17.50 8,144 -10.79 n/a n/a n/a
2017-11-13 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 77,700 125.87 9,129 232.81 n/a n/a n/a
2017-08-11 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 34,400 127.81 2,743 254.39 n/a n/a n/a
2017-05-12 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 15,100 -81.72 774 -74.98 n/a n/a n/a
2017-02-10 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 82,600 490.00 3,093 225.92 n/a n/a n/a
2016-11-10 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 14,000 28.44 949 56.86 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 10,900 31.33 605 16.12 n/a n/a n/a
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 8,300 40.68 521 -6.13 n/a n/a n/a
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 5,900 -3.28 555 13.27 n/a n/a n/a
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 6,100 15.09 490 -22.83 n/a n/a n/a
2015-08-13 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 5,300 -74.52 635 -70.76 n/a n/a n/a
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,800 38.67 2,172 49.28 n/a n/a n/a
2015-02-17 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 1,455 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 12,000 -60.00 3,970 -66.72 n/a n/a n/a
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 0.00 11,930 -12.80 n/a n/a n/a
2025-11-10 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 13,680 n/a n/a n/a
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 30,000 -26.11 7,059 -36.78 n/a n/a n/a
2024-11-12 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 40,600 -55.53 11,166 -49.67 n/a n/a n/a
2024-08-12 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 91,300 2,182.50 22,186 3,616.08 n/a n/a n/a
2024-05-10 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,000 -84.00 598 -87.52 n/a n/a n/a
2024-02-09 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,000 25.63 4,785 35.78 n/a n/a n/a
2023-12-06 2023-09-30 13F/A ALNYLAM PHARMACEUTICALS COM Put 19,900 3,524 n/a n/a n/a
2023-11-09 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 19,900 3,524 n/a n/a n/a
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 77,000 52.48 18,299 81.03 n/a n/a n/a
2022-11-10 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 50,500 910.00 10,108 1,286.56 n/a n/a n/a
2022-08-10 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 5,000 729 n/a n/a n/a
2021-05-13 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 21,200 -33.33 2,755 -40.50 n/a n/a n/a
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 31,800 7.07 4,630 5.25 n/a n/a n/a
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 29,700 -30.77 4,399 -5.80 n/a n/a n/a
2020-05-12 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 42,900 1.18 4,670 -4.36 n/a n/a n/a
2020-02-12 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 42,400 2.66 4,883 47.03 n/a n/a n/a
2019-11-08 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 41,300 54.68 3,321 71.45 n/a n/a n/a
2019-08-12 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 26,700 39.06 1,937 7.97 n/a n/a n/a
2019-05-13 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 19,200 6.08 1,794 35.91 n/a n/a n/a
2019-02-12 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 18,100 -39.46 1,320 -49.56 n/a n/a n/a
2018-11-13 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 29,900 70.86 2,617 51.80 n/a n/a n/a
2018-08-10 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 17,500 -31.10 1,724 -43.01 n/a n/a n/a
2018-05-11 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 25,400 -56.43 3,025 -59.16 n/a n/a n/a
2018-02-12 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 58,300 12.33 7,407 21.47 n/a n/a n/a
2017-11-13 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 51,900 -9.11 6,098 33.90 n/a n/a n/a
2017-08-11 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 57,100 8.14 4,554 68.29 n/a n/a n/a
2017-05-12 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 52,800 1.34 2,706 38.70 n/a n/a n/a
2017-02-10 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 52,100 26.76 1,951 -29.97 n/a n/a n/a
2016-11-10 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 41,100 14.48 2,786 39.86 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 35,900 23.79 1,992 9.45 n/a n/a n/a
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 29,000 48.72 1,820 -0.87 n/a n/a n/a
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 19,500 72.57 1,836 102.20 n/a n/a n/a
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,300 29.89 908 -12.94 n/a n/a n/a
2015-08-13 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 8,700 4,250.00 1,043 4,866.67 n/a n/a n/a
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 200 21 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.